Lv11
32 积分 2022-12-21 加入
608O Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic (PC), colorectal (CRC), and non-small cell lung cancer (NSCLC)
7小时前
求助中
Case report: diagnosis of VEXAS syndrome in a patient with therapy-resistant large vessel vasculitis
1个月前
已完结
Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study
2个月前
已完结
Resection postradioembolization in patients with single large hepatocellular carcinoma
2个月前
已完结
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2个月前
已完结
FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell-Mediated Bladder Cancer Immune Surveillance
3个月前
已完结
USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
3个月前
已完结
Regulation of the cGAS-STING Pathway
3个月前
已完结
SUMO Regulation of Ion Channels in Health and Disease
3个月前
已关闭
Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer Which is Best?
4个月前
已完结
皖公网安备34019202002308
